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Abstract
Fetal bone cells were shown to have an interesting potential for therapeutic use in bone tissue engineering due to their rapid growth rate and their
ability to differentiate into mature osteoblasts in vitro. We describe hereafter their capability to promote bone repair in vivo when combined with
porous scaffolds based on poly(L-lactic acid) (PLA) obtained by supercritical gas foaming and reinforced with 5 wt.% β-tricalcium phosphate (TCP).
Bone regeneration was assessed by radiography and histology after implantation of PLA/TCP scaffolds alone, seeded with primary fetal bone
cells, or coated with demineralized bone matrix. Craniotomy critical size defects and drill defects in the femoral condyle in rats were employed. In
the cranial defects, polymer degradation and cortical bone regeneration were studied up to 12 months postoperatively. Complete bone ingrowth
was observed after implantation of PLA/TCP constructs seeded with human fetal bone cells. Further tests were conducted in the trabecular
neighborhood of femoral condyles, where scaffolds seeded with fetal bone cells also promoted bone repair.
We present here a promising approach for bone tissue engineering using human primary fetal bone cells in combination with porous PLA/TCP
structures. Fetal bone cells could be selected regarding osteogenic and immune-related properties, along with their rapid growth, ease of cell
banking and associated safety.
© 2007 Elsevier Inc. All rights reserved.
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Introduction
Fetal bone cells were shown to proliferate, differentiate and
finally to mineralize their extra cellular matrix in vitro [1]. For
these reasons, we decided to test their association with porous
scaffolds for bone repair in vivo.
Ceramic reinforced poly(L-lactic acid) (PLA) structures
obtained by melt-extrusion followed by supercritical gas
foaming offer suitable conditions for primary human osteoblasts
to achieve a full differentiation process in vitro [2]. Moreover,
open frames are designed with defined parameters to improve the
osteoconductivity, such as porosity, pore size, and connectivity, as
well as enhanced mechanical properties [3]. Furthermore, this
technique allows producing biocompatible samples without the
use of potentially toxic organic solvents [4,5]. These structures
were recently tested in vivo for host tissue induced reactions as
well as for their osteoconductive properties [6].
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Critical size defect models (CSD) are often used to study
orthopaedic materials [7]. A CSD is defined to be the smallest
in situ bone wound that would not heal spontaneously by bone
formation during the lifespan of the animal [8]. Thus, the CSD
created on the bony vault of the cranium (calvaria) represents a
severe test for bone graft substitutes. CSDs in the calvaria have
been established for different mammalian species [9–14]. Mo-
delling on parietal bone has been applied on rats from different
strains and at various ages [10,15–18]. Three months old
Sprague–Dawley rats did not spontaneously fill 8 mm diameter
lacunae 18 weeks post-surgery [6].
Several animal models are described to test implants in
cancellous bone [19–21] and the femoral condyle is often used for
this purpose [22,23]. Due to its vascularization and the presence
of precursor cells, this location is of particular interest to assess in
parallel biodegradation and bone repair processes [24].
For cell-based approaches in bone tissue engineering, bone
marrow preparations [25], mesenchymal stem cells (MSCs)
[26,27], and osteoprogenitor cells [28] have been used. Recently,
fetal bone cells were characterized in vitro to investigate their
potential use for tissue engineering [1]. They were shown to be
able to proliferate and differentiate into mature osteoblasts
in vitro when seeded on PLA/TCP scaffolds [2].
In the present study, we describe the combination of fetal bone
cells with PLA/5 wt.% β-tricalcium phosphate (PLA/TCP)
implants for cortical and trabecular bone repair. Fetal bone cells
were used in their proliferating phase without induction of
differentiation to evaluate their osteogenic potential in vivo. In rat
cranial defects, cortical bone regeneration was assessed with
PLA/TCP implants with and without fetal bone cells as well as
with β-tricalcium phosphate matrices (designated as β-TCP
Mathys hereafter), corresponding to the composition and struc-
ture of chronOS™ scaffolds already used in clinical applications
(Mathys, Bettlach, Switzerland). In parallel, both scaffolds were
coated with demineralized bone matrix (DBM) to improve their
osteoinductivity and to compare them for cortical bone rege-
neration with scaffolds seeded with cells. To further evaluate the
osteoconduction of PLA/TCP implants and the osteogenesis
induced by fetal bone cells, PLA/ceramic structures with or
without cells were implanted in the metaphyseal trabecular
network of rat femoral condyles.
We demonstrate here for the first time, the high potential of
human fetal bone cells associated with PLA/ceramic composite
structures processed by supercritical gas foaming for their use in
cortical and trabecular bone repair.
Materials and methods
Cell sources
Human fetal bone cells were obtained from our cell bank comprising eight
donors at the end of April 2007. Biopsies were obtained in accordance with the
Ethics Committee of the University Hospital in Lausanne (Ethical Protocol 51/01).
In this study, bone cells from a fetus of 15 weeks gestational age were used
following voluntary interruption of pregnancy. Primary osteoblast cultures were
established by rinsing the tissue first with PBS (containing penicillin and
streptomycin for washing only). Afterwards, bone samples were mechanically
dissociated with a scalpel blade and transferred to 10 cm culture grade plates where
cell outgrowth was seen within 2 to 5 days under normal culture conditions:
DMEM (Invitrogen, Carlsbad, CA), 10% FCS (Sigma-Aldrich, St Louis, MO),
2 mM L-Glutamin (Invitrogen, Carlsbad, CA).
Cell culture
Fetal bone cells were maintained in culture by passaging once a week and
culturing at 37 °C in a humidified, 5% CO2 atmosphere in DMEM,10% FCS,
2 mM L-Glutamine. Culture media were changed twice a week.
Scaffold generation
The processing of foams, as well as analyses of scaffold morphology and
properties, were carried out and described in detail elsewhere [3]. Poly(L-lactic acid)
pellets (PLA; Boehringher Ingelheim, Germany), and β-tricalcium phosphate (β-
TCP) ceramic powder (Fluka, Buchs SG, Switzerland) (5 wt.%) were mixed, and
further melt-extruded using amicro-compounder (Micro 5 Compounder; DSM, The
Netherlands) [29]. Foaming was then carried out with supercritical CO2
(pureN99.995%; SL gas, Switzerland), in a custom made high-pressure chamber
(Autoclave France, France). Once CO2 was dissolved in PLA, foaming was
achieved by sudden gas release, which induces bubble nucleation and their growth.
Simultaneous cooling fixes the porous structure. PLA/5 wt.% β-TCP (PLA/TCP)
scaffolds tested in vivo in this study were processed using the following parameters:
saturating pressure of 226 bar; depressurization rate of 4.5 bar/s; cooling rate of
4.4 °C/s. In parallel, β-TCP scaffolds (β-TCP Mathys), corresponding to
chronOS™ bone substitute, were tested (Mathys, Bettlach, Switzerland). Scaffold
morphology was evaluated by micro-computed tomography, and by scanning
electron microscopy [30]. Ceramic distribution was assessed and described else-
where [29,30]. Implanted volumes were machined into cylinders (2 mm high, 8 mm
diameter for the calvaria and 3 mm high, 3 mm diameter for the condyle model).
Scaffold coating with demineralized bone matrix
Scaffold coating with DBM (National Tissue Bank, University of Pretoria,
Pretoria, Republic of South Africa) was achieved by mixing demineralized bone
particles with a fibrin sealer (Tissucol® Kit, Baxter, Vienna, Austria). Briefly,
the lyophilized fibrinogen concentrate was dissolved in aprotinin solution
(3000 KIU/ml) as described by the manufacturer. Thrombin was dissolved in
calcium chloride solution (40 μmol/ml) to a concentration of 4 IU/ml. The fibrin
gel was prepared by mixing both components at equal volumes. DBM fragments
(30 mg/scaffold) were rapidly glued on scaffold surfaces while the sealant was
still liquid (within approximately 1 min).
Microtomographic imaging
The samples were scanned using a microtomographic imaging system (μCT 40;
Scanco Medical, Bassersdorf, Switzerland) equipped with a 5 μm focal spot X-ray
tube as a source. TheX-ray tubewas operated at 70 kVp and 114μA.The integration
time was set to 300ms. CT images were reconstructed in 1024×1024 pixel matrices
from 500 projections using a standard convolution–backprojection procedure.
Images were stored in 3D arrays with an isotropic voxel size of 12 μm.
Scanning electron microscopy
Sampleswere rinsedwith PBS (Invitrogen, Carlsbad, CA) prior to fixationwith
primary glutaraldehyde fixative: 0.1 M sodium cacodylate (Polysciences Inc,
Warrington, PA), 5% glutaraldehyde (Polysciences Inc, Warrington, PA), 0.1 M
sucrose (Axon Lab AG, Baden-Dätwill, Switzerland), pH 7.4 for 45 min at 4 °C.
The fixative was then replaced by a buffered sucrose vehicle: 0.1 M sodium
cacodylate, 0.1 M sucrose, pH 7.4, for 30 min at 4 °C. After this step, bones were
placed in osmium fixative: 0.1 M sodium cacodylate, 0.1 M sucrose, 1% osmium
tetroxyde (Polysciences Inc, Warrington, PA), pH 7.4, for 60 min at 4 °C. Samples
were washed twice at room temperature with demineralized water before
dehydration and air-drying from a solution of hexamethyldisilazane (Polysciences
Inc, Warrington, PA). The sample surfaces were gold-coated during 2 min under
1 kV and observed using a scanning electron microscope Philips XL30 (FEI,
Hillsboro, OR) at a voltage of 5 kV.
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Cell seeding
Scaffolds were placed in 24-well plates and washed with complete culture
medium. Cells were seeded by direct pipetting at a density of 2×106 cells/
scaffold. This density was selected, as a good cell distribution and an
exponentional cell growth reaching the plateau after 10 days were observed in
vitro. Moreover, the cell density retained was consistent with the one used by
others for similar cell phenotype [31,32]. After 2 h, additional culture medium
was distributed around the scaffolds. They were incubated for 24 h at 37 °C in a
humidified, 5% CO2 atmosphere.
Animals and housing
All animal experiments were performed with the approval of the Veterinary
Authority from the Canton of Vaud (authorizations No. 1777 and 1878). Sprague–
Dawley albino orWistar rats (females, 84–92 days old, 275–300 g) were purchased
from Iffa Credo (Charles River Laboratories, L'Arbresle Cedex, France) for the
craniotomy and the femoral condylemodels, respectively. Animals were grouped by
3 on wood-based litters in PETcages (405×255×197 mm) equipped with Reemay
filter covers (no. E4FVCOU910, Charles River Laboratories, L'Arbresle Cedex,
France). Strictly controlled housing conditions were used: temperature: 22±2 °C,
relative humidity: 55±10%, light/dark hours schedule:12/12. They were fed a
balanced solid diet (Mouse/Rat— complete feed extrudate 3436, ProvimiKiblaAG,
Switzerland). Food and water were provided ad libitum during the experiment.
Rat surgery
Table 1 summarizes all conditions tested for the cranial and the femoral
models, respectively.
Rats were anesthetized with isoflurane 2–3.5% in oxygen. For the calvarial
surgery, once sedated, the animals were shaved and the cranial surface sterily
prepared with alcohol. The animals were placed on a heating pad to maintain
body temperature during the procedure. A midline incision (approximatively
3 cm long) was made from the nasal bone to the crest using a surgical blade. The
soft tissue and the periosteum were elevated. The craniotomy defect (8 mm) was
created with a trephine drill (no. 207421, Provet SA, Lyssach, Switzerland)
under constant saline irrigation and the underlying dura was preserved. The
resulting defect was grafted with scaffolds made either of PLA/TCP, PLA/TCP/
DBM, PLA/TCP with fetal bone cells, β-TCP Mathys, or β-TCP Mathys/DBM.
The skin was closed with stainless steel surgical clips. Postoperative analgesia
was provided by subcutaneous injection of Butorphanol Morphasol® 0.03 ml
(Dr E. Gräub AG, Bern, Switzerland). At the determined time points, animals
were sacrificed by CO2 asphyxiation. Craniotomy sites with 5 mm neighboring
bone were collected from the skull and placed in 4% buffered formaldehyde.
Aseptic surgical technique was used throughout the procedure, and each
condition was tested in six replicates. For the cranial model used in this study,
108 animals were randomly assigned to the different groups and for the three
time points, including rats undergoing sham surgery (n=6).
Implants made of PLA/TCP with or without fetal bone cells were further
tested in a drill hole model in the distal femoral condyles of rats. For this, twelve
female rats were used. Under general isoflurane anesthesia, both femoral distal
condyles in each rat were exposed. The diameter and depth of the hole created
transversally in the bone were both 3 mm. After washing the cavity with
physiological saline to remove debris, the defects were filledwith implants (PLA/
TCP and PLA/TCP with fetal bone cells, n=12 for each group). The fascia and
skin were then closed using suture material or stainless steel surgical clips,
respectively. Postoperative analgesia was provided by subcutaneous injection of
Butorphanol Morphasol® 0.03 ml. At 2 months following surgery, animals were
sacrificed by CO2 asphyxiation, and femurs were processed for histology as
described hereafter.
Histological evaluation
After fixation in 4% buffered formaldehyde, samples were dehydrated in a
series of increasing concentrations of ethanol (50–100%), defatted in xylene and
infiltrated at 4 °C with methylmethacrylate (Fluka Chemie GmbH, Buchs,
Switzerland), dibuthylphtalate (Merck Schuchardt, Hohenbrunn, Germany) and
Perkadox 16 (Dr. Grogg Chemie AG, Stettlen, Switzerland). Specimens were
embedded at room temperature in a fresh solution of acrylic resin. To visualize
bone formation, slides of 300 μm thickness were sectioned with a diamond saw-
rotating microtome (Leica® Sp1600, Leica Instruments GmbH, Nussloch,
Germany). Cranial sections were obtained frontally, at the level of the maximum
diameter of the craniotomy, and femoral sections were obtained sagittally.
Sections were radiographed, ground down to 30–40 μm and polished as des-
cribed elsewhere [33]. They were stained with toluidine blue, which in its
orthochromatic phase, stains bone components in various shades of blue,
enabling the distinction between the non-mineralized osteoid and themineralized
bone matrix. It represents the standard technology in our laboratory for the
histological staining of non-decalcified ground sections where after chemical
surface etching only toluidine blue can be used. Goldner's trichrome is not usable
for this purpose and does also not reveal more information.
For the calvaria model, ground sections were photographed at a low mag-
nification (×5.8) with a microscope (Leica M420®, Leica microsystems,
Switzerland) equipped with a digital camera (Leica DC200®). The histological
analysis was performed with respect to scaffold degradation and newly formed
bone. Regarding the formation of new bone, a semi-quantitative scoring system
was used. Briefly, a healing scorewas assigned to each implant as follows: A) bony
recovery along the dura: 0 for no repair; 1 for 0–25%; 2 for 26–50%; 3 for more
than 50% of repair, B) porous ossification inside the scaffold structures: 0 for no
ossification; 1 for ossification observed on up to 25%of the total area (scaffold plus
pores); 2 for ossification observed on up to 50% of the total area, and 3 for
ossification observed on more than 50% of the total area. In order to obtain more
representative results, two histological sections of each animal were analyzed and
subsequently, the mean value of each parameter was calculated for every animal.
The obtained healing scores were further classified into four categories, which
were: no (0), weak (≤1), moderate (≤2), and strong (≤3) healing.
For the condyle model, and for each implant, one representative section was
analyzed. Thick sections were photographed at a magnification of 16× (Leica
M420®, Leica microsystems, Switzerland) equipped with a digital camera
(Leica DC200®). Three software programs were used for image analysis (Leica
IM100®, Leica QWin® and Adobe Photoshop 7®). Only the defect area
corresponding to the implant itself was analyzed. New bone was stained
manually to ensure accurate detection during the measurement. Absolute values
were converted into percentages of the total area using Microsoft Excel®. A
student t-test was applied to assess the effect of fetal bone cells on new bone
formation within the PLA/TCP scaffolds.
Table 1
Experimental design for the cranial and femoral models
CSD craniotomy
Implants/
surgery
Comments Time points Group size
Sham surgery No implantation 12 days, 6 months,
12 months
n=6
PLA/TCP PLA+5 wt.% β-TCP 12 days, 6 months,
12 months
n=6
PLA/TCP/DBM 30 mg DBM/scaffold,
glued with Tissucol® Kit
12 days, 6 months,
12 months
n=6
PLA/TCP/fetal
bone cells
2 mio cells/scaffold,
donor 15 weeks
gestational age
12 days, 6 months,
12 months
n=6
β-TCP Mathys β-TCP scaffolds
corresponding to
chronOS™ matrice
12 days, 6 months,
12 months
n=6
β-TCP Mathys/
DBM
30 mg DBM/scaffold,
glued with Tissucol® Kit
12 days, 6 months,
12 months
n=6
Femoral condyle
Implants Comments Time points Group size
PLA/TCP PLA+5 wt.% β-TCP 2 months n=12
PLA/TCP/fetal
bone cells
2 mio cells/scaffold, donor
15 weeks gestational age
2 months n=12
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Radiography of rat specimen
The presence of newly formed bone was determined radiographically
(Faxitron X-ray systems, Hewlett Packard, Oregon, USA). Skulls were placed
with the exocranial surfaces on top of a radiographic film (Kodak Portal Pack for
Localization Imaging, Eastman Kodak Company, Rochester, NY). Samples
were imaged and processed with an image analysis software (ImageJ, Wayne
Rasband, National Institutes of Health, Bethesda, MD). Histograms of each
defect area were determined on digitized radiographs, and background values
were subtracted. Femurs were radiographed as thick sections of 300 μm, in order
to visualize bone infiltration in implants without surrounding bone.
Statistical analysis
Animals were randomly assigned to the different groups. All conditions
were tested with six replicates for the craniotomy and twelve replicates for the
femoral model. Semi-quantitative, histological analysis of bone repair and
analysis of X-rays images were performed blinded to the treatment groups.
Unless otherwise specified, results are presented as mean values with standard
deviation of the mean.
Results
Scaffold generation and quality control
Porosity and pore sizewere verified to be in the expected range
of 75–90% and 200–500 μm, respectively, for the PLA/TCP
scaffold (Fig. 1A) using micro-CT and scanning electron micros-
copy. The following values were obtained: porosity: 83.4±
2.5%; pore diameter: 390±180 μm; modulus: 121.0±12.1 MPa
Fig. 1. Scanning electronmicrographs of scaffold structures. (A) PLA 5wt.%β-TCP: porosity 83.4±2.5%, pore diameter: 390±180μm,modulus 121.0±12.1MPa. (B) Same
scaffolds made of PLA 5wt.%β-TCP, coated with DBM. (C)β-TCPMathys: porosity 75.4±0.3%, pore diameter: 410±30μm, modulus 2.70±0.44 GPa. (D) Same scaffolds
made ofβ-TCP, coatedwithDBM. (E) Fetal bone cells proliferating onPLA5wt.%β-TCP scaffolds 24 h after seeding. Black arrows indicate spreading cells. Scale bar: 200μm.
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(expected: value: 150 MPa). Furthermore, the β-TCP Mathys
scaffolds (Fig. 1C) were examined showing a porosity of 75.4±
0.3%, a pore diameter of 410±30 μm and a modulus of 2.70±
0.44 GPa.
Coating of the scaffolds with DBM was controlled by scan-
ning electron microscopy. Numerous DBM fragments could be
detected covering the outer surface of the PLA/TCP/DBM and
β-TCP Mathys/DBM scaffolds (Fig. 1B and D).
Cell adherence and scaffold infiltration was examined by
scanning electron microscopy prior to implantation (Fig. 1E)
showing proliferating cells all over the surface of the scaffolds.
Histology of cranial samples
First evidence of PLA/TCP scaffold degradation was observed
at 6 months and more advanced degradation at 12 months after
surgery. Changes concerning bulk morphology and porosity
were noted. Fragmentation was rarely observed. The structures of
β-TCPMathys were practically unchanged at the 12 months time
point which corresponded to the end of the study.
The presence of DBM debris induced symptoms of
inflammation in the PLA/TCP/DBM and β-TCP Mathys/
DBM groups at12 days after implantation. Swelling was mainly
due to local fluid influx and disappeared 3 months after surgery
as assessed in a pilot study (data not shown).
Bone healing processes were evaluated semi-quantitatively
and results are summarized in Table 2. Repair observed
12 months postoperatively are illustrated by photomicrographs
of stained cranial sections in Fig. 2, and no sign of necrosis was
noted. Sham operated animals were not able to close the defects
with new bone at this time point (Fig. 2F).
PLA/TCP: new bone formation started mainly from the edge
of the defects and along the dura showing the osteoconductive
property of these scaffolds (Table 2A, Fig. 2A). Almost no
ossification of the porous scaffold structure was observed
(Table 2B). The healing process was delayed when a layer of
fibrous tissue was present between the implants and the dura.
PLA/TCP/DBM: osteoinduction was observed around the
DMB particles present at the outer part of the scaffolds and
occured mainly on the dural side (Fig. 2B) resulting in an
improved ossification along the dura when compared to the
PLA/TCP scaffold alone (Table 2A). The new bone formed a
network with only few interconnections with the implants
themselves. This could have been due to the presence of fibrous
tissue in between the newly formed bony structures and im-
plants. As for the scaffold material alone, no ossification inside
the pores of the structure could be detected (Table 2B).
PLA/TCP seeded with fetal cells: beside ossification along
the dura confirming the osteoconductive properties of the
scaffold material (Table 2A), new bone was also forming in the
middle of the scaffold material filling its porous structure
(Table 2B, Fig. 2C). However, the filling of pores did not
correlate to the bone formation at the interface between the dura
and the construct. Complete bridging of the defect with new
bone was observed within this group. Mature mineralized
bone with osteocytes were found in the porous structures and
Table 2
Histological semi-quantitative evaluation of bone repair, 12 days, 6 months and 12 months after implantation in skulls
A. Ossification along the dura
PLA/TCP PLA/TCP/DBM PLA/TCP/fetal cells
Duration of implantation (weeks) 12/7 24 48 12/7 24 48 12/7 24 48
0 0.3 1.2 0 0.5 2.5 0 0.8 1.3
(0–0) (0–1) (0–3) (0–0) (0–1) (1–3) (0–0) (0–2) (1–3)
Bone Repair None Weak Moderate None Weak Strong None Weak Moderate
β-TCP Mathys β-TCP Mathys/DBM
Duration of implantation (weeks) 12/7 24 48 12/7 24 48
0 0.7 0 0 0.8 2.7
(0–0) (0–1) (0–0) (0–0) (0–1) (2–3)
Bone repair None Weak None None Weak Strong
B. Porous ossification
PLA/TCP PLA/TCP/DBM PLA/TCP/fetal cells
Duration of implantation (weeks) 12/7 24 48 12/7 24 48 12/7 24 48
0 0.2 0.3 0 0 0 0 0.2 1.2
(0–0) (0–1) (0–1) (0–0) (0–0) (0–0) (0–0) (0–1) (0–3)
Bone ingrowth None Weak Weak None None None None Weak Moderate
β-TCP Mathys β-TCP Mathys/DBM
Duration of implantation (weeks) 12/7 24 48 12/7 24 48
0 1.2 2 0 1 1.8
(0–0) (1–2) (1–3) (0–0) (1–1) (1–3)
Bone ingrowth None Weak Moderate None Weak Moderate
Histological evaluation was undertaken according to the scoring system described in the Materials and methods section. Values are expressed as mean (min.−max.)
for each group of implants at the corresponding time point.
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front lines of osteoblasts were observed, directly on the osteoid
(Fig. 3).
β-TCP Mathys: a good osteoconduction of the ceramic was
observed, and the volume of the scaffolds were partly ossified,
with numerous pores already filledwith bone (Table 2B, Fig. 2D).
In contrast to the PLA/TCP scaffolds, almost no ossification along
the dura occured (Table 2A).
β-TCP Mathys/DBM: together with the osteoconduction
inherent to scaffolds made of β-TCP (Table 2B, Fig. 2D),
osteoinduction was observed around the DMB particles located
on the dural side of the scaffolds (Table 2A, Fig. 2E). The new
bone formed a grid infiltrating superficially the porous structures
of the implants.
Histology of femoral samples
Indications of PLA/TCP scaffold resorption were apparent
2 months postoperatively. Changes were structural and
concerned volume and porosity. Particular changes were more
obvious when fetal cells were seeded on bone substitutes, and
fragmentation was rarely observed. Bone healing assessed at
this time point is illustrated by photomicrographs of stained
femoral sections in Fig. 4.
PLA/TCP: implants were surrounded by new bone, formed
either by prolongations of the cortical shell or by expansions
of the metaphysiseal trabecular lattice, confirming the osteo-
conductivity of these structures observed in the skulls.
Infiltrations of newly synthesized bone were strong at the
periphery of the scaffolds and remained reduced in the center
(Fig. 4A and C).
PLA/TCP seeded with fetal bone cells: implants were also
well anchored into the neighboring bone. Notable stronger
infiltrations of new bone were assessed in the volume of the
scaffolds when compared with PLA/TCP alone (Fig. 4B and D).
The histomorphometrical analysis showed a statistically sig-
nificant difference regarding the quantity of new bone formation
within PLA/TCP implants loaded with fetal cells in comparisson
with PLA/TCP implants alone (+89%; p=4×10−6).
Radiography of rat specimen
The presence of newly formed bone was confirmed radio-
graphically in the cranial defects (Fig. 5). Whereas no new bone
formation occurred in the sham control group, an increase in the
area of radiopacity representing bone repair was observed
within the skull defects between 12 days, 6 and 12 months for
all PLA/TCP implants tested resulting in statistically significant
differences over time. Furthermore, differences between PLA/
TCP and PLA/TCP+fetal bone cells were significant at
12 months (+40%; p=0.004). PLA/TCP/DBM scaffolds were
significantly different from PLA/TCP structures starting from
the first time point and this is thought to be due to the coating
itself. Due to β-TCPMathys cements high refringence to X-rays
resulting in an intensity close to saturation, new bone formation
Fig. 2. Photomicrographs of histological sections of the cranial vaults 12 months after implantation. (A) PLA 5 wt.% β-TCP, (B) PLA 5 wt.% β-TCP/DBM, (C) PLA
5 wt.% β-TCP with fetal bone cells, (D) β-TCP Mathys, (E) β-TCP Mathys/DBM, and (F) Sham operated group. Best repair images are shown. No healing was
observed in the sham operated group. Samples were fixed in formaldehyde and processed for histological analysis. To visualize bone formation, frontal sections of
300 μm thickness were ground down to 30–40 μm, polished, and stained with toluidine blue. Scale bar: 1 mm.
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could not be detected using this method for the β-TCP Mathys
and β-TCP Mathys/DBM groups. Therefore, values obtained
for these groups were not treated statistically.
Bone infiltration was also observed in the femoral implants,
and seeding of the implants with human fetal bone cells did
promote this phenomenon (Fig. 6).
Discussion
The aim of this study was to test the association of fetal bone
cells with ceramic reinforced PLA scaffolds for tissue
engineering. As animal models, the CSD craniotomy and the
femoral condyle approaches in rats were chosen to follow
cortical and trabecular bone repair processes. Key findings were
the observation of complete bone bridging 12 months after
implantation in skulls of PLA porous structures seeded with
human fetal bone cells, and a strong induction of trabecular
bone ingrowth in femoral condyles 2 months after surgery. As
almost no new bone formation could be observed in the pores
when implanting the scaffold material alone in the craniotomy
model, the observed ossification can be assigned to the
osteogenic potential of the fetal cells.
Firstly, we investigated PLA/ceramic resorption, as it is
particularly important for bone implants that degradation does
not occur before bone healing. Scaffold degradation is
dependent on bone turnover and could be influenced by other
factors, such as the access to vasculature, the mechanical
loading, and the metabolism of degradation products [34]. Pure
PLA scaffolds were shown to be degradable in rats [19] and in
rabbits [35]. One advantage of combining ceramic and polymer
is to control resorption rates [36]. In a pilot study in cranial
defects in rats, the same PLA/ceramic scaffolds as used in this
study did not show signs of alteration during the first 3 months
after implantation (unpublished results), whereas fragmentation
was observed after 18 weeks [6]. In the present work, and
confirming these observations, changes in scaffold morphology
were not noticed before 6 months post-surgery in the cranial
model. The biological inertness of the skull compared with long
bones is suggested to be due to a poor blood supply and a relative
deficiency of bone marrow [12]. In the highly vascularized and
mechanically stressed femoral condyle model, alterations of the
implant structures were already observed at 2 months and were
concomitant with bone remodelling. The presence of human
fetal bone cells did enhance this process. Thus, PLA/TCP
scaffolds obtained by critical gas foaming showed an interesting
behaviour, as their degradation was associated with tissue repair.
Secondly, we characterized the ability of the structures to
guide osteoprogenitor cells leading to new bone formation.
Morphologically and embryologically, the calvaria develops
from a membrane precursor and thus resembles the membranous
bones of the face. Intramembranous ossification is characterized
by the direct mineralization of a highly vascular connective
tissue membrane. Trephine defects were shown to heal not only
by ingrowth from the rim, but also by proliferation of peri-
vascular mesenchymal-type cells of the dura mater [37]. In the
first few days of bony repair, cells are migrating, attaching, and
differentiating into osteoblasts to propagate bone growth [7]. It is
known that porosity and pore size tend to affect osseointegration.
Interconnected pores or open porosity is required for vascular-
ization and nutrient diffusion. Thus, interconnection of the ma-
cropores plays a crucial role for cell migration and colonization
of the inner scaffold. This parameter was not specifically
evaluated in this work, and a partial interconnection could ex-
plain why, as in other studies [38,39], the new bone was mainly
seen to be lining the osteoconductive walls of the composite
matrix. Optimization of the foaming conditions to tailor foam
parameters to trabecular bone properties are described elsewhere
[3]. Foaming conditions were adjusted in order to get open
porosity and 200–500 μm pore diameters. Porosity and pore size
can be adjusted playing with saturation pressure and tempera-
ture, depressurization rates and cooling rates. For example, high
pressure will correspond to high CO2 concentration in the
molten polymer and therefore a higher porosity. According to
Boyan et al. 1996 [40], in the case of ceramic scaffolds, a
macroporosity of 200–400 μm is needed to promote bone cell
attachment, and a large available surface area will favour cell
attachment and spreading. However, in the case of the PLA/TCP
Fig. 3. Photomicrographs of histological sections of the cranial vaults 12 months
after implantation of PLA 5 wt.% β-TCP seeded with fetal bone cells.
(A) Ossification of the scaffold and (B) details showing the process of bone
formation within the pores. Metachromatically stained osteoid (green arrow) is
deposited by a front of osteoblasts (red arrow), whereas mature bone with
numerous osteocytes is seen in the vicinity (white arrow). Samples were
formaldehyde fixed and processed for histological analysis. To visualize bone
formation, frontal sections of 300 μm thickness were ground down to 30–40 μm,
polished, and stained with toluidine blue. (⁎) Scaffold localization. Scale bars:
(A) 200 μm and (B) 100 μm.
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biocomposite, fetal bone cell development did not seem to be
affected by differences in porosity and pore size in vitro [2]. In a
preliminary in vivo study concerning PLA/TCP obtained by
supercritical gas foaming, only one type of porous structure,
porosity and pore size was tested and bone repair was assessed
[6]. The aim of the present study was to evaluate the osteo-
genicity of fetal bone cells in vivo when associated to PLA/TCP
scaffolds. Thus, structural parameters were kept identical to the
preliminary study.
In contrast to this observation, the already clinically used β-
TCP Mathys material showed enhanced osteoconduction
resulting in ossification within the porous structures of the
implants. Lytic zones resulting from polymer hydrolysis [41] or
degradation-induced inflammation and bone resorption
[42] were observed in canine models with scaffolds made of
poly(L-lactic-co-glycolic acid) associated with BMP-2. In this
study, although local bone degradation could have occurred,
radiopacity of X-rays was increasing in a time-dependent
fashion with all scaffold groups made of PLA indicating rather
bone formation than resportion. This analytical method coupled
to histology was suitable to follow bone formation in PLA/TCP
scaffolds and to describe the precise location of the newly
formed bone. Osteogenic properties of human fetal bone cells
lead to bone formation within the scaffold volumes, whereas
DBM coating did facilitate bone formation along the dura.
Moreover, the thin trabeculae of the metaphysis were found
to progress around and into the implants, leading to improved
implant integration and repair of the femoral defects. Best
results were obtained when fetal bone cells were present in the
scaffolds, and healing of the cranial and femoral defects with
PLA/ceramic structures seeded with human fetal bone cells
were observed by histology and confirmed by radiography. The
Fig. 4. Histology and histomorphometrical analysis of femoral implants 2 months after implantation. Representative photomicrographs of histological femoral sections
of different animals are shown. (A and C) PLA 5 wt.% β-TCP alone and (B and D) PLA 5 wt.% β-TCP seeded with fetal bone cells. Samples were fixed in
formaldehyde and processed for histological analysis. To visualize bone formation, sagittal sections of 300 μm thickness were ground down to 30–40 μm, polished and
stained with toluidine blue. Scale bar: 500 μm. Histomorphometrical analysis of sections from PLA 5 wt.% β-TCP alone and PLA 5 wt.% β-TCP seeded with fetal
bone cells was performed using one representative section per implant (12 implants per group). Thick sections were photographed and only the defect area
corresponding to the implant itself was analyzed. New bone was stained manually to ensure accurate detection during the measurement. Absolute values
were converted into percentages of the total area. Results are given as mean values with associated standard deviation of the mean. The difference between PLA 5 wt.%
β-TCP and PLA 5 wt.% β-TCP+fetal bone cells was significant (+89%; p=4×10−6).
561M.-O. Montjovent et al. / Bone 42 (2008) 554–564
osteogenic properties observed in xenogeneic implants might
have been reduced due to adverse response of the hosts, as
reported with MSCs from rats used in mice [43]. Although if
immunoprivilege of fetal and adult MSCs is described [44],
immune response in xenogeneic species cannot be excluded.
However, as there was no immune response detectable after
12 months corresponding to a long-term follow-up in the rat, no
later immune response is expected. Further studies must be
undertaken to evaluate the respective actions of host and donor
cells in the healing process observed. It might be possible that
fetal bone cells initiate the process of bone repair which could
be then continued by the host cells. A preliminary study showed
that human cells were still detectable in cranial implants
4 weeks after surgery (unpublished results).
Based on these promising results, human fetal bone cells in
combination with PLA/TCP scaffolds will be integrated in long
bones defects in larger animals for further preclinical
evaluation.
Summary
The in vivo behaviour of PLA/ceramic foams in combination
with human fetal cells was assessed in terms of scaffold
resorption as well as cortical and trabecular bone repair. The
Fig. 5. Radiographic analysis of cranial trephine defects in adult rat skulls. The exocranial surfaces were exposed on top of a radiographic film. Samples were imaged
and processed with an image analysis software. Histograms of each defect area were determined on digitized radiographs, and background values were subtracted.
X-rays were taken 12 days, 6 months, and 12 months after the surgical intervention. Results are presented as mean values with associated standard deviation of the
mean. Statistically significant differences over time within each group of implants are noted as follows: (⁎) for pb0.05; (⁎⁎) for pb0.01 and (⁎⁎⁎) for pb0.001.
Due to β-TCP Mathys cements high refringence to X-rays showing intensities close to saturation, new bone formation was not detectable in the β-TCP Mathys
and β-TCP Mathys/DBM groups, and values obtained for these groups were not treated statistically (n.a.). No new bone formation occurred in the sham group.
Fig. 6. Roentgenograms of femoral drill defects in rats 2 months after the surgical intervention. Femurs were radiographed as thick sections of 300 μm, in order to
visualize bone infiltration in implants without surrounding bone. Representative images of PLA 5 wt.% β-TCP implants without cells (A and B) and with human fetal
bone cells (C and D) are shown. Implantation sites are indicated with circles.
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degradation rate was coupled to the rate of tissue regeneration,
leading to a structural integrity of the constructs. The presence of
human fetal bone cells did improve the overall healing process
when compared to the scaffold material alone. A complete
reconstruction of the cranial vault was observed within the
porous architecture of PLA/ceramic constructs seeded with
human fetal cells. We conclude that PLA/ceramic architectures
obtained by melt-extrusion coupled with supercritical gas
foaming offer suitable conditions for host tissue integration
and that the addition of human fetal cells can further improve
their performance. This new approach to create composite
structures and subsequently combine them with human fetal
bone cells is promising for tissue engineering, especially for
applications in maxillofacial bone repair and during revision of
total joint replacement. In the perspective for use in tissue
engineering, fetal bone cells could be selected regarding
osteogenic and immune-related properties (unpublished results),
along with their rapid growth, ease of cell banking and
associated safety.
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